Gynäkomastie: Diagnostik und Therapie

Gynäkomastie - Pubertät - Anabolika - viriles Mammakarzinom - antiandrogene Therapie Prostatakarzinom - Tamoxifen - Klinefelter-Syndrom

gynecomastia - puberty - anabolic steroids - male breast cancer - antiandrogene treatment prostate cancer - tamoxifen - Klinefelter’s syndrome

Literatur

• 1 Autorino R, Perdona S. et al . Gynecomastia in patients with prostate cancer: update on treatment options.  rostate Cancer Prostatic Dis. 2006;  9 109-114
• 2 Boccardo F, Rubagotti A. et al . Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.  J Clin Oncol. 2005;  23 808-815
• 3 Braunstein G D. Clinical practice. Gynecomastia.  N Engl J Med. 2007;  357 1229-1237
• 4 Carvajal A, Macias D. et al . Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System.  Drug Saf. 2007;  30 527-531
• 5 Chalazonitis A N, Theodossiades G D. et al . Bilateral gynecomastia with microcalcifications in an HIV infected hemophilia A patient after HAART.  Jbr-Btr. 2006;  89 328
• 6 Cuculi F, Suter A. et al . Spironolactone-induced gynecomastia.  CMAJ. 2007;  176 620
• 7 DDG, L.v. d. S.A.d. D.D.G. AWMF-Leitlinien 2004; Register Nr. 013/039. 
• 8 de la Torre A, Ramada Benlloch F, Sánchez Ballester F. et al . Management of male sterility in patients taking anabolic steroids.  Arch Esp Urol. 2005;  58 241-244
• 9 Di Lorenzo G, Perdona S. et al . Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.  J Urol. 2005;  174 2197-2203
• 10 Ewertz M, Holmberg L. et al . Risk factors for male breast cancer – a case-control study from Scandinavia.  Acta Oncol. 2001;  40 467-471
• 11 Fradet Y, Egerdie B. et al . Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.  Eur Urol. 2007;  52 106-114
• 12 Giordano S H. A review of the diagnosis and management of male breast cancer.  Oncologist. 2005;  10 471-479
• 13 Henley D V, Lipson N. et al . Prepubertal gynecomastia linked to lavender and tea tree oils.  N Engl J Med. 2007;  356 479-485
• 14 Hochberg Z. Practical Algorithms in Pediatric Endocrinology. Freiburg; Karger 2007
• 15 Karagiannis A, Tziomalos K. et al . Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.  Nephrol Dial Transplant. 2007;  22 293
• 16 Khan H N, Blamey R W. Endocrine treatment of physiological gynaecomastia.  BMJ. 2003;  327 301-302
• 17 Khan H N, Rampaul R. et al . Management of physiological gynaecomastia with tamoxifen.  Breast. 2004;  13 61-65
• 18 Kliesch S, Behre H M. et al . Rationale Therapie der Hitzewallungen unter Hormonentzugsbehandlung bei Patienten mit fortgeschrittenem Prostatakarzinom.  Dtsch Med Wochenschr. 1997;  122 940-945
• 19 Lazala C, Saenger P. Pubertal gynecomastia.  J Pediatr Endocrinol Metab. 2002;  15 553-560
• 20 Narula H S, Carlson H E. Gynecomastia.  Endocrinol Metab Clin North Am. 2007;  36 497-519
• 21 Nuttall M C, Harris J P. et al . The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.  BJU Int. 2007;  99 243-244
• 22 Perdona S, Autorino R. et al . Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial.  Lancet Oncol. 2005;  6 295-300
• 23 Prisant L M, Chin E. Gynecomastia and hypertension.  J Clin Hypertens (Greenwich). 2005;  7 245-248
• 24 Rose L I, Underwood R H. et al . Pathophysiology of spironolactone-induced gynecomastia.  Ann Intern Med. 1977;  87 398-403
• 25 Smith R A, Saslow D. et al . American Cancer Society guidelines for breast cancer screening: update 2003.  CA Cancer J Clin. 2003;  53 141-169
• 26 Tashkandi M, Al-Qattan M M. et al . The surgical management of high-grade gynecomastia.  Ann Plast Surg. 2004;  53 17-20
• 27 Than RS, Vasudevan D. Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse.  Fertil Steril. 2003;  79
• 28 Thonnessen D, Wenz F. Radiotherapeutic prophylaxis of gynecomastia.  J Clin Oncol. 2005;  23 5845
• 29 UpToDate Prevention and treatment of gynecomastia, UpToDate 2007 95 Sawyer Road Waltham, MA 02453 United States. 
• 30 Yavuz M, Kesiktas E. et al . Lighted retractor-assisted transaxillary approach in gynecomastia correction.  Ann Plast Surg. 2006;  57 370-373
• 31 Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients.  J Clin Endocrinol Metab. 2004;  89 6208-6217